Reproductive Biology and Endocrinology · 2019 · 27 citations · 37 references
MedicineGynecologyOncologyCell TherapyChemotherapyReproductive MedicineMenstrual CycleOogenesisOvarian CycleOvarian FunctionOvarian PhysiologyAnti-müllerian Hormone AssessmentApoptosis In Ovarian TissueEstradiol LevelsEstrous Cycle PhasesOvarian ApoptosisOvarian Function AssessmentPremature Ovarian FailureSerum Follicle-stimulating Hormone
BACKGROUND: To investigate the therapeutic effects of menstrual blood derived mesenchymal stem cells (MB-MSCs) combined with Bushen Tiaochong recipe (BSTCR) on epirubicin induced premature ovarian failure (POF) in mice. METHODS: Twenty-four female C57BL/6 mice of 6-8 weeks were intraperitoneally injected with epirubicin to induce POF, and then they were randomized into 4 groups of 6 mice each and treated with PBS, MB-MSCs, BSTCR, and MB-MSCs combined with BSTCR, respectively. Six mice of the same age were used as controls. Vaginal smear, TUNEL and hematoxylin-eosin staining were to observe estrous cycles, ovarian cell apoptosis and follicles. Enzyme-linked immunosorbent analysis determined serum estradiol, follicle-stimulating hormone (FSH) and anti-Müllerian hormone (AMH) levels. RT-qPCR and Western Blot analysis were to determine GADD45b, CyclinB1, CDC2 and pCDC2 expressions. RESULTS: Epirubicin treatment resulted in a decrease in the number of primordial, primary, secondary and antral follicles, an increase in the number of atretic follicles and ovarian cell apoptosis, a decrease in estradiol and AMH levels, an increase in FSH levels, and estrous cycle arrest. However, MB-MSCs combined with BSTCR rescued epirubicin induced POF through down-regulating GADD45b and pCDC2 expressions, and up-regulating CyclinB1 and CDC2 expressions. The combined treatment showed better therapeutic efficacy than BSTCR or MB-MSCs alone. CONCLUSIONS: MB-MSCs combined with BSTCR improved the ovarian function of epirubicin induced POF mice, which might be related to the inhibition of GADD45b expression and the promotion of CyclinB1 and CDC2 expressions. The combined treatment had better therapeutic efficacy than BSTCR or MB-MSCs alone.
37
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Arduino Verdecchia, Silvia Francisci, Hermann Brenner et al. · The Lancet Oncology · 2007 · 1.3K citations
Medicine, Biostatistics, Oncology +17
Endometrial regenerative cells: A novel stem cell population
Xiaolong Meng, Thomas E. Ichim, Jie Zhong et al. · Journal of Translational Medicine · 2007 · 658 citations · Full text
Mark N. Levine, V. Bramwell, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 1998 · 623 citations
Medicine, Oncology, Pharmacotherapy +10
Dongmei Lai, Fangyuan Wang, Xiaofen Yao et al. · Journal of Translational Medicine · 2015 · 250 citations · Full text